Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RCELthis companyAvita Medical Inc.	$18.08	-1.98×	-5.77×	1.34×	-3.2×	-278.6%	82.1%	-59.4%	-67.8%	291.8%	-113.0%	-34.3%	-2.77×	-0.87×	-8.5×	0.57×	0.0%	3	-9.92	2	C
APYXApyx Medical Corporation	$2.95	-12.96×	10.15×	2.79×	-33.8×	-284.7%	36.0%	-12.2%	-21.2%	-77.1%	-11.6%	-6.2%	2.71×	-1.66×	-1.15×	5×	0.0%	3	0.84	1	D+
HYPRHyperfine, Inc.	$0.71	-2.28×	2.25×	6.8×	-1.67×	-270.1%	49.8%	-273.4%	-262.3%	-86.8%	-84.7%	-31.6%	0.01×	1.01×	0×	4.34×	0.0%	4	-6.81	1	C-
LUCDLucid Diagnostics Inc.	$0.42	-1.58×	10.16×	23.61×	-1.79×	-873.4%	-60.3%	-1054.8%	-1232.7%	-530.4%	-135.1%	-41.8%	2.36×	0.16×	-2,256.36×	1.31×	0.0%	3	-13.58	2	C
NSPRInspireMD, Inc.	$0.68	-2.34×	2.37×	14.56×	-2.59×	-939.0%	29.5%	-547.0%	-543.3%	-88.4%	-82.2%	-28.1%	0.06×	0.12×	0×	5.74×	0.0%	2	-11.16	2	C+
OVIDOvid Therapeutics Inc.	$2.99	-6.79×	0.92×	16.57×	-7.03×	-129.6%	95.9%	-585.2%	-240.1%	-13.3%	-29.5%	-31.9%	0.1×	-0.02×	0×	10.91×	0.0%	1	10.63	2	C+
Peer median	—	-2.34×	2.37×	14.56×	-2.59×	-284.7%	36.0%	-547.0%	-262.3%	-86.8%	-82.2%	-31.6%	0.1×	0.12×	0×	5×	0.0%	3	-6.81	2	—